PatientPartner, an innovative health-tech startup dedicated to advancing patient engagement, has successfully raised $7 million in its latest Seed Round of funding. This significant investment, spearheaded by LionBird and FCA Venture Partners, includes $3.5 million in new capital and $3.5 million in convertible debt from Alethea Capital and additional strategic investors. Founded by Forbes Under…
In a significant stride towards revolutionizing treatments for one of the most challenging pediatric brain tumors, TippingPoint Biosciences has announced the successful closure of pre-seed investments. This funding round has garnered support from renowned organizations, including the Pediatric Brain Tumor Foundation, the Sontag Foundation, the Yuvaan Tiwari Foundation, and BrightEdge, the venture capital arm of…
Re-Leased, a forward-thinking property software firm founded in New Zealand, has successfully closed an oversubscribed US$12.5 million funding round. This significant capital influx, led by Movac with participation from Icehouse Ventures and existing investors, is set to fuel the company’s expansion and the enhanced integration of AI within its software suite. The funding will accelerate…
In a significant boost to the fight against lung cancer, HEPTA Medical, a pioneering medical device company specializing in minimally invasive thermal ablation therapy, has successfully completed a €5.7 million Series A funding round. The investment was led by BPI France and supported by M&L Healthcare and Clery IG. Founded in 2019 by Sofinnova Partners…
Sonoma Biotherapeutics, Inc., a leading clinical-stage biotechnology firm specializing in engineered regulatory T cell (Treg) therapies, has achieved a significant milestone with a $45 million payment from Regeneron Pharmaceuticals, Inc. This milestone underscores the fruitful partnership between the two companies in developing advanced treatments for autoimmune diseases. The payment marks a pivotal point in Sonoma…
Ceres Imaging, the leading data and analytics provider for the agricultural sector, has rebranded as CeresAI, underscoring its commitment to advanced AI-driven solutions for agribusinesses and financial services. This strategic move highlights CeresAI’s decade-long expertise in computer vision and machine learning, aiming to revolutionize data accuracy and decision-making processes for large-scale farms, insurers, and lenders….
Cognitive Credit, a pioneer in data and analytics for corporate credit markets, has successfully closed a $10 million Series B funding round in the second quarter of 2024. This latest investment was spearheaded by ETFS Capital with continued support from existing investor XTX Ventures. The infusion of capital will enable Cognitive Credit to expand its…
eGenesis, a trailblazer in biotechnology with a focus on developing human-compatible engineered organs, has announced the successful completion of a $191 million Series D financing round. This substantial investment will propel the advancement of eGenesis’s lead product candidate, EGEN-2784, through its first-in-human clinical trials for kidney transplants. Additionally, the funds will facilitate the expansion of…
Arsenal Biosciences, Inc. (ArsenalBio), a pioneering force in programmable cell therapy, has announced the successful closure of an oversubscribed $325 million Series C financing round. This significant funding boost reflects a growing confidence in ArsenalBio’s innovative approach to advanced CAR T-cell therapies targeting solid tumors. The Series C round attracted a host of new investors,…
Revefi has announced a significant milestone with the completion of a $20 million Series A financing round. The funding, spearheaded by Icon Ventures and supported by Mayfield, GTM Capital, and StepStone Group, will drive the launch of Raden, an innovative AI data engineer poised to transform data management. Raden, the world’s first AI data engineer…
